Literature DB >> 17111467

Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study.

Hui-chun Li1, Qiao-zhen Chen, Ying Ma, Jun-fu Zhou.   

Abstract

OBJECTIVE: To examine changes of blood oxidative-antiovidative level in schizophrenic patients and its relationship with clinical symptoms.
METHODS: Forty-six Chinese patients met DSM-IV (Diagnostic and Statistical Manual of Mental Disorders-IV) criteria for schizophrenia and fifty age- and sex-matched healthy controls were enrolled in the present study. Baseline psychiatric symptom severity was assessed with brief psychiatric rating scale, positive and negative syndrome scale on the blood draw day. Fresh blood samples were collected to measure levels of nitric oxide and lipid peroxide in plasma as well as activities of superoxide dismutase, catalase and glutathione peroxidase in red blood cells by spectrophotometric assays simultaneously.
RESULTS: Comparison of the biochemical parameters indicated that the level of nitric oxide and lipid peroxide increased in patient group, which represented a positive correlation with positive scale scores; while the activities of three critical enzymes decreased and showed a negative linear correlation.
CONCLUSION: This study showed that there are dysregulation of free radical metabolism and poor activities of the antioxidant defense systems in schizophrenic patients. Excess free radicals formation may play a critical role in the etiology of schizophrenia. Using antioxidants might be an effective therapeutic approach to partially alleviate or prevent the symptoms of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17111467      PMCID: PMC1661668          DOI: 10.1631/jzus.2006.B0981

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  35 in total

1.  Red blood cell nitric oxide levels in patients with schizophrenia.

Authors:  H Herken; E Uz; H Ozyurt; O Akyol
Journal:  Schizophr Res       Date:  2001-12-01       Impact factor: 4.939

2.  Effects of nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester on phencyclidine-induced effects in rats.

Authors:  M Bujas-Bobanovic; H A Robertson; S M Dursun
Journal:  Eur J Pharmacol       Date:  2000-12-01       Impact factor: 4.432

3.  Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study.

Authors:  Jesus Ramirez; Rodrigo Garnica; Marie-Catherine Boll; Sergio Montes; Camilo Rios
Journal:  Schizophr Res       Date:  2004-06-01       Impact factor: 4.939

4.  Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients.

Authors:  J K Yao; S Leonard; R D Reddy
Journal:  Schizophr Res       Date:  2000-03-16       Impact factor: 4.939

5.  Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.

Authors:  Anilkumar Pillai; Vinay Parikh; Alvin V Terry; Sahebarao P Mahadik
Journal:  J Psychiatr Res       Date:  2006-03-27       Impact factor: 4.791

Review 6.  Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia.

Authors:  S P Mahadik; D Evans; H Lal
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-04       Impact factor: 5.067

7.  Dopamine effect on the mitochondria potential in B lymphocytes of schizophrenic patients and normal controls.

Authors:  Ahmed M Elkashef; Heba Al-Barazi; Dianne Venable; Ivory Baker; James Hill; Jose Apud; Richard Jed Wyatt
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-01       Impact factor: 5.067

8.  Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex.

Authors:  P R Montague; C D Gancayco; M J Winn; R B Marchase; M J Friedlander
Journal:  Science       Date:  1994-02-18       Impact factor: 47.728

9.  Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.

Authors:  J K Yao; R Reddy; L G McElhinny; D P van Kammen
Journal:  J Psychiatr Res       Date:  1998 Nov-Dec       Impact factor: 4.791

10.  Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia.

Authors:  Eiji Suzuki; Toshio Nakaki; Makoto Nakamura; Hitoshi Miyaoka
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

View more
  13 in total

1.  Epicatechin inhibits human plasma lipid peroxidation caused by haloperidol in vitro.

Authors:  Anna Dietrich-Muszalska; Bogdan Kontek; Beata Olas; Jolanta Rabe-Jabłońska
Journal:  Neurochem Res       Date:  2011-11-12       Impact factor: 3.996

Review 2.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

3.  Different effects of L-arginine on morphine tolerance in sham and ovariectomized female mice.

Authors:  Reza Karami; Mahmoud Hosseini; Fatimeh Khodabandehloo; Leila Khatami; Zahra Taiarani
Journal:  J Zhejiang Univ Sci B       Date:  2011-12       Impact factor: 3.066

4.  Lipopolysaccharide-induced radical formation in the striatum is abolished in Nox2 gp91phox-deficient mice.

Authors:  Hans-Willi Clement; Juan F Vazquez; Olaf Sommer; Philip Heiser; Henning Morawietz; Ulrich Hopt; Eberhard Schulz; Ernst von Dobschütz
Journal:  J Neural Transm (Vienna)       Date:  2009-10-29       Impact factor: 3.575

Review 5.  Antioxidants as potential therapeutics for neuropsychiatric disorders.

Authors:  Chirayu D Pandya; Kristy R Howell; Anilkumar Pillai
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-11-02       Impact factor: 5.067

6.  Mitochondrial Dysfunction in Schizophrenia: Determination of Mitochondrial Respiratory Activity in a Two-Hit Mouse Model.

Authors:  Cécile Monpays; Jessica Deslauriers; Philippe Sarret; Sylvain Grignon
Journal:  J Mol Neurosci       Date:  2016-03-31       Impact factor: 3.444

7.  Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia.

Authors:  Maju Mathew Koola; Samir Kumar Praharaj; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2019-05-17

8.  Oxidative stress in schizophrenia.

Authors:  Marija Bošković; Tomaž Vovk; Blanka Kores Plesničar; Iztok Grabnar
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

9.  Polyphenols from Berries of Aronia melanocarpa Reduce the Plasma Lipid Peroxidation Induced by Ziprasidone.

Authors:  Anna Dietrich-Muszalska; Justyna Kopka; Bogdan Kontek
Journal:  Schizophr Res Treatment       Date:  2014-06-25

10.  Generation of superoxide anion radicals and platelet glutathione peroxidase activity in patients with schizophrenia.

Authors:  Anna Dietrich-Muszalska; Anna Kwiatkowska
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-05       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.